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Hepatic haemangioma is the commonest tumour of the li-
ver and usually remains asymptomatic. Giant hepatic hae-
mangioma is defined as one of more than 4 cm in diameter.
We report here a case of giant haemangioma of the liver pre-
senting with abdominal pain and distension.
A 52-year-old woman presented with a 2-year history of
right upper quadrant pain and abdominal distension with no
other symptoms. At physical examination, the liver was en-
larged, with a smooth surface. Laboratory investigations re-
vealed mild anaemia; liver function tests were normal.
Hepatitis B and C virus markers were negative, and the al-
pha-fetoprotein level was normal. Ultrasound showed a large
heterogeneous tumour with a hyperechoic pattern involving
the right lobe of the liver. Magnetic resonance imaging
(MRI) showed a huge hypodense mass in the right lobe of
the liver, measuring about 33 cm and prolonged to the pelvis.
The hepatic parenchyma was almost totally eclipsed by the le-
sion. The lesion showed peripheral nodular enhancement on
earlier series and became isointense with the liver parenchyma
in the late phase. It was typical of a cavernous haemangioma.
No other lesions were found at other body sites.
The patient was told she had a giant haemangioma of the
liver and was referred to the surgery department. The patient,
however, refused surgical treatment, citing fear as the reason.
She also refused follow-up.
Cavernous haemangioma is found in 0.4–7.3% of autopsied
patients,1 and many haemangiomas are incidentally identified
by abdominal ultrasound, computed tomography or MRI.
Many hepatic haemangiomas grow slowly and remain asymp-
tomatic. A giant haemangioma can cause symptoms and re-
quires treatment.2 A hepatic haemangioma should also be
treated if the patient concurrently develops haemorrhage, ab-
scess, heart failure, jaundice or Kasabach–Merritt syndrome
or if it suddenly ruptures or carries a high risk of rupture.3
Each of these complications can result in death. The indica-
tions for surgical resection are: a rapid increase in size, long-
term pain and discomfort despite analgesic drugs, a high risk
for thrombosis inside the tumour and a high risk for rupture
with haemoperitoneum.4 In the case reported here, surgery
was indicated because of the tumour size (Figs. 1–3).
In summary, giant haemangioma of the liver can cause
symptoms such as abdominal pain and distension and should
be treated surgically. The size and location of a lesion influence
the surgeon’s decision to perform either segmental resection or
enucleation. In general, both methods are safe and well toler-
ated by patients. Surgical resection may not be possible in cer-
tain cases because of the massive or diffuse nature of the lesion
or comorbid conditions. Embolisation shrinks the tumour,
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Figure 1: T2 weighted coronal MR image. The hepatic parench-
yma is almost totally eclipsed by the hyperintense lesion.
thereby minimising the risk for complications. Other
techniques mentioned in the literature include radiofrequency
ablation, surgical ligation of feeding vessels, hepatic irradia-
tion and orthotropic liver transplantation.5
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